tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

HK:3692 Stock Latest News

Hansoh Pharmaceutical Announces Interim Dividend for 2025
Company AnnouncementsHansoh Pharmaceutical Announces Interim Dividend for 2025
15d ago
3692
Hansoh Pharmaceutical Adjusts Interim Dividend Dates Due to Weather
PremiumCompany Announcements
Hansoh Pharmaceutical Adjusts Interim Dividend Dates Due to Weather
15d ago
3692
Hansoh Pharmaceutical’s XINYUE Gains Second Indication Approval in China
PremiumCompany Announcements
Hansoh Pharmaceutical’s XINYUE Gains Second Indication Approval in China
1M ago
3692
Hansoh Pharmaceutical Announces New Share Placement to Raise HK$3.9 Billion
PremiumCompany Announcements
Hansoh Pharmaceutical Announces New Share Placement to Raise HK$3.9 Billion
2M ago
3692
Hansoh Pharmaceutical Declares Interim Dividend for H1 2025
PremiumCompany Announcements
Hansoh Pharmaceutical Declares Interim Dividend for H1 2025
2M ago
3692
Hansoh Pharmaceutical Reports Strong Growth and Key Drug Approvals in H1 2025
PremiumCompany AnnouncementsHansoh Pharmaceutical Reports Strong Growth and Key Drug Approvals in H1 2025
2M ago
3692
Hansoh Pharmaceutical Schedules Board Meeting for Interim Results
Premium
Company Announcements
Hansoh Pharmaceutical Schedules Board Meeting for Interim Results
2M ago
3692
Hansoh Pharmaceutical Successfully Concludes AGM with Key Resolutions Passed
Premium
Company Announcements
Hansoh Pharmaceutical Successfully Concludes AGM with Key Resolutions Passed
4M ago
3692
Hansoh Pharmaceutical’s Aumolertinib Mesilate Tablets Approved for UK Market
PremiumCompany Announcements
Hansoh Pharmaceutical’s Aumolertinib Mesilate Tablets Approved for UK Market
4M ago
3692
Hansoh Pharmaceutical Enters Strategic License Agreement with Regeneron
PremiumCompany Announcements
Hansoh Pharmaceutical Enters Strategic License Agreement with Regeneron
4M ago
3692
Hansoh Pharmaceutical’s Third Biologics License Application for XINYUE Accepted
PremiumCompany Announcements
Hansoh Pharmaceutical’s Third Biologics License Application for XINYUE Accepted
4M ago
3692
Hansoh Pharma’s HS-20118 Tablets Gain Clinical Trial Approval
PremiumCompany Announcements
Hansoh Pharma’s HS-20118 Tablets Gain Clinical Trial Approval
4M ago
3692
Hansoh Pharmaceutical Gains Approval for Clinical Trials of Innovative Drug
PremiumCompany AnnouncementsHansoh Pharmaceutical Gains Approval for Clinical Trials of Innovative Drug
4M ago
3692
Hansoh Pharmaceutical Receives Approval for Clinical Trials of HS-10510 Tablets
Premium
Company Announcements
Hansoh Pharmaceutical Receives Approval for Clinical Trials of HS-10510 Tablets
4M ago
3692
Hansoh Pharmaceutical Announces 2025 Annual General Meeting Agenda
Premium
Company Announcements
Hansoh Pharmaceutical Announces 2025 Annual General Meeting Agenda
4M ago
3692
Hansoh Pharmaceutical’s Ameile Gains Fourth Indication Approval for NSCLC Treatment
PremiumCompany Announcements
Hansoh Pharmaceutical’s Ameile Gains Fourth Indication Approval for NSCLC Treatment
5M ago
3692
Hansoh Pharma’s HS-20089 Gains Breakthrough Therapy Status in China
PremiumCompany Announcements
Hansoh Pharma’s HS-20089 Gains Breakthrough Therapy Status in China
5M ago
3692
Hansoh Pharmaceutical Grants RSUs to Employees and Executive Director
PremiumCompany Announcements
Hansoh Pharmaceutical Grants RSUs to Employees and Executive Director
5M ago
3692
Hansoh Pharmaceutical Announces Final Dividend for 2024
PremiumCompany Announcements
Hansoh Pharmaceutical Announces Final Dividend for 2024
5M ago
3692
Hansoh Pharmaceutical Secures Approval for New Drug in China
PremiumCompany AnnouncementsHansoh Pharmaceutical Secures Approval for New Drug in China
6M ago
3692
Hansoh Pharmaceutical’s HS-20093 Receives Breakthrough Therapy Designation
Premium
Company Announcements
Hansoh Pharmaceutical’s HS-20093 Receives Breakthrough Therapy Designation
6M ago
3692
Hansoh Pharmaceutical Gains Approval for Clinical Trials of Innovative Cancer Drug
Premium
Company Announcements
Hansoh Pharmaceutical Gains Approval for Clinical Trials of Innovative Cancer Drug
6M ago
3692

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >